ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)

Clinical trial NCT01933529 · UNKNOWN

Trial details

NCT number: NCT01933529
Sponsor: Claes-Göran Östenson
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Type 2 Impaired Glucose Tolerance Impaired Fasting Glucose

Start date: 2013-10-01
Primary completion: 2014-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.